Abstract: The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.

Abstract: The presence of a cardiac pulse in a patient is determined by evaluating fluctuations in an electrical signal that represents a measurement of the patient's transthoracic impedance. Impedance signal data obtained from the patient is analyzed for a feature indicative of the presence of a cardiac pulse. Whether a cardiac pulse is present in the patient is determined based on the feature in the impedance signal data. Electrocardiogram (ECG) data may also be obtained in time coordination with the impedance signal data. Various applications for the pulse detection of the invention include detection of PEA and prompting PEA-specific therapy, prompting defibrillation therapy and/or CPR, and prompting rescue breathing depending on detection of respiration.

Abstract: The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.

Abstract: An external defibrillator includes a therapy delivery circuit, a sensor, and a processor. The therapy delivery circuit is configured to be electrically charged and to deliver electrical therapy to a patient. The sensor is configured to sense a physiological condition of the patient and generate data indicative of a probability that therapy will be delivered to the patient. The processor is configured to analyze data generated by the sensor to determine whether there is a threshold level of the probability that the therapy delivery will be delivered to the patient, if the probability is at least at the threshold level, charge the therapy delivery circuit, and determine whether therapy delivery is advisable based on the physiological condition of the patient after determining whether the probability is at least at the threshold level.

Abstract: Polymer emulsion compositions for use in printing inks and printing inks made from the compositions are provided. The emulsion compositions include an aqueous continuous phase containing water and a dissolved carboxylic acid-functional support polymer. The dispersed phase of the emulsion composition contains crosslinked, dispersed polymer particles. The emulsion compositions also include at least one multivalent metal crosslinker and at least one stabilizing agent. The polymer emulsion compositions display superior printability properties in inks and other coatings formulated with them, yet are stable at elevated temperatures for long periods of time.

Abstract: The presence of a cardiac pulse in a patient is determined by evaluating physiological signals in the patient. In one embodiment, a medical device evaluates two or more different physiological signals, such as phonocardiogram (PCG) signals, electrocardiogram (ECG) signals, patient impedance signals, piezoelectric signals, and accelerometer signals for features indicative of the presence of a cardiac pulse. Using these features, the medical device determines whether a cardiac pulse is present in the patient. The medical device may also be configured to report whether the patient is in a VF, VT, asystole, or PEA condition, in addition to being in a pulseless condition, and prompt different therapies, such as chest compressions, rescue breathing, defibrillation, and PEA-specific electrotherapy, depending on the analysis of the physiological signals. Auto-capture of a cardiac pulse using pacing stimuli is further provided.

Abstract: Stable water-borne polymer compositions are disclosed. The compositions comprise a water-borne polymer, a metal cross-linking agent and a stabilizing agent comprising from 2 to 10 carbon atoms and at least two functional groups independently selected from hydroxy and carboxy. The stabilizing agent is present a 1.4 mole percent or more of the amount of metal cross-linking agent. Inventive compositions are particularly suitable for use in water-based inks and coatings. Methods of making and using the coating compositions are also described.

Abstract: A method of delivering electrical therapy to a patient by a medical device includes activating the medical device and performing a first analysis of a first set of data signals sensed by the medical device. If the first analysis shows the first set of data signals meets a first criterion, then charging of an energy delivery circuit is commenced upon completion of the first analysis. A second analysis of a second set of data signals from the patient is performed, and if the second analysis determines that the second set of data signals meet a second criterion, the therapy is delivered. The steps of performing the first analysis and performing the second analysis may be begun at substantially the same time. The step of charging may overlap in time with the step of performing a second analysis. The medical device may be an external defibrillator and the therapy may be a defibrillating shock.

Abstract: A hollow shaped socket insert adapter rotatively driven by a single socket driver for tightening, loosing, and removing various sizes of nuts/bolts.

Abstract: The presence of a cardiac pulse in a patient is determined by evaluating fluctuations in an electrical signal that represents a measurement of the patient's transthoracic impedance. Impedance signal data obtained from the patient is analyzed for a feature indicative of the presence of a cardiac pulse. Whether a cardiac pulse is present in the patient is determined based on the feature in the impedance signal data. Electrocardiogram (ECG) data may also be obtained in time coordination with the impedance signal data. Various applications for the pulse detection of the invention include detection of PEA and prompting PEA-specific therapy, prompting defibrillation therapy and/or CPR, and prompting rescue breathing depending on detection of respiration.

Abstract: The presence of a cardiac pulse in a patient is determined by evaluating fluctuations in an electrical signal that represents a measurement of the patient's transthoracic impedance. Impedance signal data obtained from the patient is analyzed for a feature indicative of the presence of a cardiac pulse. Whether a cardiac pulse is present in the patient is determined based on the feature in the impedance signal data. Electrocardiogram (ECG) data may also be obtained in time coordination with the impedance signal data. Various applications for the pulse detection of the invention include detection of PEA and prompting PEA-specific therapy, prompting defibrillation therapy and/or CPR, and prompting rescue breathing depending on detection of respiration.

Abstract: The presence of a cardiac pulse in a patient is determined by evaluating fluctuations in an electrical signal that represents a measurement of the patient's transthoracic impedance. Impedance signal data obtained from the patient is analyzed for a feature indicative of the presence of a cardiac pulse. Whether a cardiac pulse is present in the patient is determined based on the feature in the impedance signal data. Electrocardiogram (ECG) data may also be obtained in time coordination with the impedance signal data. Various applications for the pulse detection of the invention include detection of PEA and prompting PEA-specific therapy, prompting defibrillation therapy and/or CPR, and prompting rescue breathing depending on detection of respiration.

Abstract: Stable water-borne polymer compositions are disclosed. The compositions comprise a water-borne polymer, a metal cross-linking agent and a stabilizing agent comprising from 2 to 10 carbon atoms and at least two functional groups independently selected from hydroxy and carboxy. The stabilizing agent is present a 1.4 mole percent or more of the amount of metal cross-linking agent. Inventive compositions are particularly suitable for use in water-based inks and coatings. Methods of making and using the coating compositions are also described.

Abstract: A system and method for offering a financial product to a customer in real-time while the customer is conducting a transaction over a network. In response to received identification information regarding the customer over the network, the present system and method retrieves data related to the identification information, determines if the customer qualifies to receive an offer of the financial product in response to the retrieved data, and then offers the financial product to the customer if the customer qualifies. If the customer accepts the offer of the financial product, the financial product is made immediately usable by the customer. This entire process is performed while the customer is conducting a transaction on-line or via telephone. In other words, the process is conducted in real-time. Because the determination of the qualification for an offer is conducted in real-time, the back-end process required to re-check the customer's credit data before approving the offer is eliminated.

Abstract: Stable water-borne polymer compositions are disclosed. The compositions comprise a water-borne polymer, a metal cross-linking agent and a stabilizing agent comprising from 2 to 10 carbon atoms and at least two functional groups independently selected from hydroxy and carboxy. The stabilizing agent is present at 1.4 mole percent or more of the amount of metal cross-linking agent. Inventive compositions are particularly suitable for use in water-based inks and coatings. Methods of making and using the coating compositions are also described.

Abstract: A soil substitute material is configured with ground construction and demolition (C&D) waste materials suitable for use in grading or construction projects in industrial, commercial, and after conducting specific preparation steps is useful in selective residential settings, road and highway grading, backfill and cap materials at environmental sites, alternative daily cover at landfills, rough grading for roadbeds and constructing athletic fields, and landfill construction and operation as a stabilized and compactable construction material.

Abstract: An apparatus configured to provide a defibrillation shock or pacing stimuli to a patient and methods for controlling the apparatus are provided. The method includes obtaining and analyzing physical parameters of the patient to determine whether the patient has a heart condition appropriately treated with a defibrillation shock or pacing stimuli, if the appropriate treatment is pacing stimuli, automatically determining a magnitude of the pacing stimuli and supplying the pacing stimuli to the patient at the magnitude and at a pacing rate.